The importance of the DNAM-1/CD155 axis in tumor control was first described in a mouse lymphoma model where a high expression of CD155 induced a robust response mediated by NK cells in a DNAM-1 dependent mechanism (reviewed in [16]). The gene discussed is CD226; the disease is neoplasm.